StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
945
This month
13
This week
6
This year
103
Publishing Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 11
4
2023 - 12 - 08
4
2023 - 10 - 30
4
2023 - 10 - 04
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
5
2023 - 06 - 12
5
2023 - 06 - 08
4
2023 - 04 - 26
5
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
5
2023 - 02 - 17
7
2023 - 02 - 16
4
2023 - 02 - 13
5
2023 - 02 - 08
4
2023 - 01 - 16
4
2022 - 09 - 21
3
2022 - 09 - 19
6
2022 - 09 - 16
3
2022 - 09 - 14
3
2022 - 09 - 13
3
2022 - 09 - 09
3
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 22
3
2022 - 06 - 17
5
2022 - 05 - 27
5
2022 - 05 - 17
3
2022 - 04 - 26
4
2022 - 04 - 06
3
2022 - 03 - 25
5
2022 - 03 - 23
3
2022 - 03 - 22
4
2022 - 03 - 17
3
2022 - 03 - 16
3
2022 - 03 - 14
3
2022 - 03 - 08
3
2022 - 03 - 04
4
2022 - 03 - 01
3
2022 - 02 - 28
3
2021 - 12 - 22
3
2021 - 12 - 20
3
2021 - 11 - 12
3
2021 - 11 - 04
3
2021 - 10 - 22
3
2021 - 10 - 21
3
2021 - 10 - 20
3
2021 - 10 - 08
3
2021 - 10 - 01
3
Sector
Commercial services
8
Communications
7
Consumer durables
5
Consumer non-durables
14
Consumer services
2
Distribution services
4
Electronic technology
18
Finance
3
Health care and social assistance
1
Health services
13
Health technology
945
Industrial services
1
Information
4
Manufacturing
134
Mining, quarrying, and oil and gas extraction
2
N/a
65
Non-energy minerals
1
Process industries
13
Producer manufacturing
16
Professional, scientific, and technical services
17
Retail trade
2
Technology services
16
Tags
Agreement
8
Alzheimer's
10
America
67
Antibody
8
Application
8
Approval
13
Biosimilar
32
Breast
13
Business
9
Cancer
91
Cell
9
Chmp
10
Diabetes
15
Diagnostics
17
Disease
61
Drug
85
Earnings
18
Europe
15
Expansion
10
Expected
35
Eye
15
Fda
22
Financial
24
Global
228
Growing
43
Growth
235
Health
19
Immunotherapy
11
Infection
9
Kisqali
11
Leukemia
10
Liver
11
Market
592
N/a
945
Novartis
132
People
13
Pharma
13
Pharmaceuticals
17
Pipeline
12
Positive
15
Potential
10
Reach
34
Report
194
Research
118
Respiratory
11
Results
38
Risk
10
Sales
9
Sclerosis
13
Set
15
Study
15
T-cell
11
Technology
12
Therapeutics
109
Therapy
64
Treatment
113
Trial
16
Update
10
Vaccine
10
Year
12
Entities
3m company
8
Abbott laboratories
104
Abbvie inc.
218
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
12
Alcon inc.
14
Alkermes plc
7
Amgen inc.
167
Astellas pharma inc
70
Astrazeneca plc
171
Autolus therapeutics plc
7
Bausch health companies inc.
61
Baxter international inc.
41
Becton, dickinson and company
16
Biogen inc.
46
Biontech se
9
Boston scientific corporation
13
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
79
Celyad oncology sa
6
Chinook therapeutics, inc.
7
Csl ltd
9
Danaher corporation
10
Eli lilly and company
118
Endo international plc
19
General electric company
8
Generation bio co.
6
Genmab a/s
12
Gilead sciences, inc.
25
Glaxosmithkline plc
264
Grifols sa
10
Ionis pharmaceuticals, inc.
7
Jazz pharmaceuticals plc
13
Johnson & johnson
181
Koninklijke philips n.v.
17
Mallinckrodt plc
17
Medtronic plc
29
Mesoblast ltd
6
Novartis ag
945
Novo nordisk a/s
27
Orange
7
Orchard therapeutics plc
8
Perrigo company
7
Pfizer, inc.
65
Precision biosciences, inc.
6
Prestige consumer healthcare inc.
6
Puma biotechnology inc
6
Reckitt benckiser group plc
9
Regeneron pharmaceuticals, inc.
12
Regenxbio inc.
7
Sanofi
281
Smith & nephew plc
7
Stryker corporation
9
Takeda pharmaceutical company limited
45
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
205
Thermo fisher scientific inc
48
Ucb s.a.
8
Viatris inc.
114
Symbols
AAPL
1194
ABB
1426
ABBV
783
ABLZF
1165
ABT
1563
ACN
600
AMGN
569
ARVL
4175
AVGO
583
BDX
690
BNPQF
1736
BNPQY
1736
CSCO
896
DELL
575
DHR
725
DOW
555
ERIC
1599
EXTR
581
F
636
FNCTF
6849
FRBA
597
GE
886
GLAXF
616
GOOG
1061
GOOGL
1061
GSK
789
HON
1784
HUBS
1400
IBM
652
INTC
947
IT
593
JNJ
2886
LLY
1120
LMT
575
LTUM
971
LYV
717
MDT
1147
MMM
926
MS
3854
MSFT
1193
MT
588
NOC
588
NOK
900
NOKBF
974
NVS
1115
NVSEF
945
ORCL
1155
PCRFF
650
PCRFY
650
PHG
956
PPRUF
1063
PPRUY
1064
SAP
1475
SAPGF
1230
SNOW
796
SNY
2816
SNYNF
2233
TMO
1409
VZ
1204
XYF
654
Exchanges
Amex
4
Nasdaq
945
Nyse
945
Crawled Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 11
4
2023 - 12 - 08
4
2023 - 10 - 30
4
2023 - 10 - 04
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
4
2023 - 06 - 12
5
2023 - 06 - 08
4
2023 - 04 - 28
4
2023 - 04 - 26
5
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
4
2023 - 02 - 17
7
2023 - 02 - 16
4
2023 - 02 - 14
4
2023 - 01 - 16
4
2022 - 12 - 15
4
2022 - 10 - 06
3
2022 - 09 - 28
3
2022 - 09 - 26
3
2022 - 09 - 21
3
2022 - 09 - 19
6
2022 - 09 - 16
3
2022 - 09 - 14
3
2022 - 09 - 13
4
2022 - 09 - 09
3
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
5
2022 - 05 - 27
5
2022 - 05 - 17
3
2022 - 04 - 26
4
2022 - 04 - 06
3
2022 - 03 - 25
5
2022 - 03 - 23
3
2022 - 03 - 22
4
2022 - 03 - 17
3
2022 - 03 - 16
3
2022 - 03 - 14
4
2022 - 03 - 08
3
2022 - 03 - 04
4
2022 - 02 - 28
3
2021 - 12 - 20
3
2021 - 11 - 12
3
2021 - 11 - 04
3
2021 - 10 - 21
3
2021 - 10 - 20
3
2021 - 10 - 08
3
2021 - 10 - 01
3
Crawled Time
00:00
40
00:20
9
01:00
42
02:00
25
03:00
33
04:00
19
04:20
8
05:00
23
06:00
58
07:00
34
08:00
25
08:20
4
09:00
39
10:00
28
11:00
38
11:01
1
12:00
54
12:20
10
12:30
6
13:00
13
13:15
1
13:20
6
13:30
3
14:00
25
14:15
1
14:20
10
14:30
7
14:49
1
15:00
35
15:15
1
15:20
15
15:30
13
16:00
43
16:20
3
17:00
47
18:00
46
19:00
41
20:00
34
20:20
3
21:00
26
22:00
40
23:00
35
Source
investors.biomarin.com
1
ir.voyagertherapeutics.com
2
www.globenewswire.com
173
www.perion.com
1
www.precisionbiosciences.com
3
www.prnewswire.com
764
www.voyagertherapeutics.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
N::A
symbols :
NVSEF
save search
Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published:
2024-04-17
(Crawled : 10:00)
- prnewswire.com
TMO
|
News
|
$543.03
0.28%
300K
|
Health Technology
|
-4.36%
|
O:
-0.26%
H:
0.03%
C:
-1.55%
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
0.28%
|
O:
0.87%
H:
0.16%
C:
-0.59%
RGNX
|
$15.925
-1.15%
120K
|
Health Technology
|
-4.57%
|
O:
-1.43%
H:
2.27%
C:
-3.18%
global
dna
market
Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
Published:
2024-04-17
(Crawled : 06:00)
- globenewswire.com
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
0.28%
|
O:
0.87%
H:
0.16%
C:
-0.59%
kesimpta
sclerosis
novartis
show
benefits
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published:
2024-04-16
(Crawled : 14:00)
- prnewswire.com
VTRS
|
$11.2
0.72%
1M
|
Health Technology
|
-1.77%
|
O:
-0.53%
H:
0.0%
C:
-1.24%
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-1.19%
|
O:
-1.46%
H:
0.0%
C:
0.0%
PHG
|
$20.065
0.43%
200K
|
Health Technology
|
-2.52%
|
O:
-1.21%
H:
0.0%
C:
0.0%
GSK
|
$39.685
1.06%
380K
|
Health Technology
|
-2.22%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
VRNA
|
$15.995
-0.65%
81K
|
Health Technology
|
1.9%
|
O:
1.65%
H:
2.43%
C:
0.87%
reach
treatment
research
market
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
Published:
2024-04-16
(Crawled : 11:00)
- globenewswire.com
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-1.19%
|
O:
-1.46%
H:
0.0%
C:
0.0%
REGN
|
$894.35
0.04%
140K
|
Health Technology
|
-1.51%
|
O:
-1.94%
H:
0.43%
C:
-0.34%
OCUL
|
News
|
$5.07
-13.48%
2.6M
|
Health Technology
|
-3.1%
|
O:
-1.03%
H:
3.66%
C:
1.7%
ocular
key
leaders
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published:
2024-04-15
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-0.29%
|
O:
-1.75%
H:
0.85%
C:
0.85%
AZNCF
|
$138.24
800
|
Health Technology
|
-0.47%
|
O:
2.1%
H:
0.0%
C:
-2.52%
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-1.19%
|
O:
-1.46%
H:
0.0%
C:
0.0%
GSK
|
$39.685
1.06%
380K
|
Health Technology
|
-2.22%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
BAX
|
$39.945
0.74%
430K
|
Health Technology
|
-0.85%
|
O:
-0.1%
H:
0.13%
C:
-1.08%
ABBV
|
News
|
$164.91
0.15%
1.2M
|
Health Technology
|
2.16%
|
O:
0.32%
H:
0.96%
C:
0.22%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-2.9%
|
O:
-2.13%
H:
0.0%
C:
0.0%
BMRN
S
|
$89.63
-0.49%
190K
|
Health Technology
|
-0.46%
|
O:
-0.72%
H:
0.0%
C:
0.0%
AZN
|
$68.545
0.27%
1.2M
|
Health Technology
|
-0.68%
|
O:
-0.64%
H:
0.45%
C:
-0.04%
AMGN
|
$265.32
0.98%
550K
|
Health Technology
|
-0.22%
|
O:
0.41%
H:
0.0%
C:
0.0%
set
therapeutics
market
New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published:
2024-04-15
(Crawled : 18:00)
- globenewswire.com
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-1.19%
|
O:
-1.46%
H:
0.0%
C:
0.0%
fabhalta
nephropathy
for
novartis
show
Novartis tender offer for MorphoSys AG commences
Published:
2024-04-11
(Crawled : 09:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-0.49%
|
O:
-0.32%
H:
0.48%
C:
-0.17%
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-1.57%
|
O:
0.32%
H:
0.04%
C:
-0.56%
MOR
|
$18.0
-0.28%
33K
|
Health Technology
|
0.31%
|
O:
0.69%
H:
0.0%
C:
-0.39%
for
novartis
Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published:
2024-04-10
(Crawled : 09:00)
- prnewswire.com
ALPMF
|
$9.17
16K
|
Health Technology
|
-10.96%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.16%
|
O:
-1.67%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
520K
|
Manufacturing
|
-10.79%
|
O:
-0.29%
H:
0.0%
C:
-1.97%
VTRS
|
$11.2
0.72%
1M
|
Health Technology
|
-5.12%
|
O:
-0.6%
H:
1.03%
C:
0.52%
TMO
|
News
|
$543.03
0.28%
300K
|
Health Technology
|
-9.54%
|
O:
-2.01%
H:
0.0%
C:
0.0%
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-2.71%
|
O:
-1.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-4.25%
|
O:
-0.32%
H:
0.0%
C:
0.0%
JAZZ
|
$109.03
-0.22%
66K
|
Health Technology
|
-7.38%
|
O:
-1.71%
H:
0.57%
C:
0.37%
disorders
system
set
market
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published:
2024-04-08
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
0.01%
|
O:
2.24%
H:
0.0%
C:
-0.8%
AZNCF
|
$138.24
800
|
Health Technology
|
1.57%
|
O:
-3.43%
H:
6.21%
C:
6.21%
VTRS
|
$11.2
0.72%
1M
|
Health Technology
|
-5.76%
|
O:
-0.25%
H:
1.1%
C:
-0.17%
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-2.83%
|
O:
-0.05%
H:
0.43%
C:
-0.27%
BMY
|
$48.56
0.54%
1.8M
|
Health Technology
|
-5.88%
|
O:
-0.08%
H:
0.04%
C:
-0.35%
BHC
|
$8.655
0.64%
750K
|
Health Technology
|
-16.04%
|
O:
0.38%
H:
0.0%
C:
-7.27%
ABBV
|
News
|
$164.91
0.15%
1.2M
|
Health Technology
|
-1.64%
|
O:
0.77%
H:
1.63%
C:
0.35%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-3.02%
|
O:
0.84%
H:
0.0%
C:
0.0%
AZN
|
$68.545
0.27%
1.2M
|
Health Technology
|
1.21%
|
O:
0.18%
H:
0.3%
C:
0.19%
eczema
dermatitis
set
therapeutics
market
New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
Published:
2024-04-06
(Crawled : 20:20)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
Email alert
Add to watchlist
leqvio
novartis
therapy
show
Positron Emission Tomography Market size is set to grow by USD 725.97 mn from 2024-2028,increasing prevalence of chronic conditions worldwide boost the market- Technavio
Published:
2024-04-03
(Crawled : 06:00)
- prnewswire.com
CAJPY
|
News
|
$28.42
29K
|
n/a
|
-3.18%
|
O:
-0.3%
H:
0.54%
C:
0.54%
CAJFF
|
News
|
$29.0664
760
|
Electronic Technology
|
-2.61%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-1.43%
|
O:
-2.86%
H:
0.17%
C:
0.17%
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-1.41%
|
O:
0.04%
H:
0.46%
C:
-0.08%
PHG
|
$20.065
0.43%
200K
|
Health Technology
|
1.15%
|
O:
1.0%
H:
0.0%
C:
0.0%
worldwide
set
market
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
Published:
2024-04-01
(Crawled : 12:00)
- globenewswire.com
NAMS
|
$19.97
2.73%
23K
|
n/a
|
-10.51%
|
O:
6.23%
H:
2.77%
C:
-10.21%
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-3.42%
|
O:
0.47%
H:
0.23%
C:
-0.99%
pharma
business
Carisma Therapeutics Announces Changes to its Board of Directors
Published:
2024-04-01
(Crawled : 11:00)
- prnewswire.com
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-3.42%
|
O:
0.47%
H:
0.23%
C:
-0.99%
CRIS
|
$15.12
-0.66%
1.4K
|
Health Technology
|
41.72%
|
O:
0.7%
H:
16.87%
C:
16.87%
therapeutics
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.56
0.54%
1.8M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
News
|
$66.495
0.51%
1.9M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$265.32
0.98%
550K
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
$28.805
1.68%
80K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
$290.38
220
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$164.91
0.15%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
LASIK Surgery Market size to record USD 1.24 bn growth from 2024-2028, Increasing medical tourism for LASIK surgery is one of the key market trends, Technavio
Published:
2024-03-28
(Crawled : 22:00)
- prnewswire.com
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$107.24
1.87%
2M
|
Health Technology
|
Email alert
Add to watchlist
ALC
|
$79.46
1.26%
250K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
one
key
medical
growth
market
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Published:
2024-03-28
(Crawled : 19:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
AUTL
|
$4.73
-1.46%
99K
|
Health Technology
|
Email alert
Add to watchlist
medical
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published:
2024-03-28
(Crawled : 15:30)
- prnewswire.com
GLAXF
|
$20.2
510
|
Health Technology
|
-4.72%
|
O:
0.99%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-2.92%
|
O:
0.52%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$146.39
0.45%
1.8M
|
Health Technology
|
-7.14%
|
O:
1.32%
H:
0.0%
C:
0.0%
GSK
|
$39.685
1.06%
380K
|
Health Technology
|
-7.89%
|
O:
0.02%
H:
0.51%
C:
-0.3%
LLY
|
$728.765
-2.3%
1.5M
|
Health Technology
|
-3.52%
|
O:
0.28%
H:
1.71%
C:
-0.3%
BMY
|
$48.56
0.54%
1.8M
|
Health Technology
|
-9.3%
|
O:
0.26%
H:
2.03%
C:
1.57%
AMGN
|
$265.32
0.98%
550K
|
Health Technology
|
-7.46%
|
O:
0.54%
H:
0.0%
C:
0.0%
antibody
research
global
Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published:
2024-03-27
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
$20.2
510
|
Health Technology
|
-4.72%
|
O:
0.99%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-7.02%
|
O:
-1.17%
H:
0.0%
C:
-0.89%
AZNCF
|
$138.24
800
|
Health Technology
|
0.45%
|
O:
0.89%
H:
0.78%
C:
0.78%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-2.92%
|
O:
0.52%
H:
0.0%
C:
0.0%
GSK
|
$39.685
1.06%
380K
|
Health Technology
|
-7.89%
|
O:
0.02%
H:
0.51%
C:
-0.3%
BMY
|
$48.56
0.54%
1.8M
|
Health Technology
|
-9.3%
|
O:
0.26%
H:
2.03%
C:
1.57%
ABBV
|
News
|
$164.91
0.15%
1.2M
|
Health Technology
|
-8.42%
|
O:
0.36%
H:
0.72%
C:
0.61%
ABT
|
News
|
$107.24
1.87%
2M
|
Health Technology
|
-5.06%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-8.47%
|
O:
-0.96%
H:
0.0%
C:
0.0%
AZN
|
$68.545
0.27%
1.2M
|
Health Technology
|
0.01%
|
O:
-0.12%
H:
0.25%
C:
-0.63%
AMGN
|
$265.32
0.98%
550K
|
Health Technology
|
-7.46%
|
O:
0.54%
H:
0.0%
C:
0.0%
abbvie
set
canada
key
market
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
Published:
2024-03-27
(Crawled : 20:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
ERAS
|
$1.78
-0.56%
140K
|
|
-6.31%
|
O:
17.48%
H:
6.94%
C:
-14.88%
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-2.92%
|
O:
0.52%
H:
0.0%
C:
0.0%
LLY
|
$728.765
-2.3%
1.5M
|
Health Technology
|
-3.52%
|
O:
0.28%
H:
1.71%
C:
-0.3%
business
year
financial
results
Radiopharmaceuticals Market to Reach $11.6 Billion by 2034 as Cancer Treatment Gains Traction - Future Market Insights, Inc.
Published:
2024-03-25
(Crawled : 15:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.86%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-3.27%
|
O:
-0.08%
H:
0.15%
C:
-0.44%
LLY
|
$728.765
-2.3%
1.5M
|
Health Technology
|
-2.57%
|
O:
0.06%
H:
0.96%
C:
0.26%
CAH
|
$107.19
1.12%
160K
|
Distribution Services
|
-3.46%
|
O:
0.02%
H:
0.73%
C:
-0.02%
LNTH
|
News
|
$63.86
2.46%
130K
|
Health Technology
|
5.61%
|
O:
0.1%
H:
1.98%
C:
-0.08%
reach
cancer
treatment
market
← Previous
1
2
3
4
5
6
7
8
9
…
47
48
Next →
Gainers vs Losers
79%
21%
Top 10 Gainers
AGBA
|
News
|
$1.22
205.0%
86M
|
Finance
EGOX
|
$0.0606
68.33%
250M
|
NVFY
|
$3.45
63.51%
20M
|
Consumer Durables
CHRO
|
$1.66
35.51%
70K
|
n/a
INDO
|
$5.43
33.09%
10M
|
Energy Minerals
ZCMD
|
$1.86
28.28%
29M
|
Commercial Services
PAPL
|
$2.07
26.22%
550K
|
RWOD
|
$10.08
26.05%
5.6M
|
n/a
HUSA
4
|
$2.07
23.95%
2.1M
|
Energy Minerals
SRFM
4
|
$0.6
21.29%
850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.